Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19500
Title: Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/administration &,dosage/*therapeutic use,Area Under Curve,Carboplatin/administration & dosage,Carcinoma, Non-Small-Cell Lung/*drug therapy/pathology,Disease Progression,Dose-Response Relationship, Drug,Drug Administration Schedule,Female,Humans,Leukopenia/chemically induced,Lung Neoplasms/*drug therapy/pathology,Male,Middle Aged,Nervous System Diseases/chemically induced,Paclitaxel/administration & dosage,Prognosis,Survival Analysis,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19500
ISSN: 0923-7534
Link: http://www.ncbi.nlm.nih.gov/pubmed/10997806
http://annonc.oxfordjournals.org/content/11/7/799.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Kosmidis-2000-Paclitaxel (175 mg_m.pdf607.32 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons